As the healthcare industry accelerates its adoption of artificial intelligence, a fundamental and pressing question looms over the entire technological transformation: Who is this future actually being built for?

This critical issue takes center stage in the latest episode of The Business of Health with Chip Kahn, a weekly podcast series that connects the intricate dots between healthcare business, policy, and everyday patient experiences. In Episode 19 of the show’s dedicated artificial intelligence series, host Charles N. “Chip” Kahn sits down with prominent emergency physician, health equity strategist, and bestselling author Dr. Uche Blackstock to explore the intersection of advanced technology, systemic bias, and patient care.

Dr. Blackstock, the founder and chief executive officer of Advancing Health Equity, brings a wealth of clinical experience and structural critique to the discussion. A former associate professor in the Department of Emergency Medicine at NYU Langone Health and former faculty director of recruitment, retention, and inclusion in the institution’s Office of Diversity Affairs, she has long been a leading voice in examining racism and inequity within American medicine. Her expertise has earned her widespread acclaim, including a spot on TIME’s inaugural TIME100 Health list in 2024, as well as leadership recognitions from Forbes and Fortune. She is also the author of the New York Times bestseller Legacy: A Black Physician Reckons with Racism in Medicine.

During the episode, Dr. Blackstock challenges the prevailing narrative that artificial intelligence tools are inherently objective or neutral. She argues that without deliberate, community-centered oversight, automated systems risk replicating and even exacerbating the historical failures of the American healthcare system, ultimately leaving marginalized patients behind.

About This Episode: The AI Revolution and Healthcare Equity

The healthcare industry is currently undergoing a massive paradigm shift, with artificial intelligence being integrated into diagnostics, administrative workflows, clinical decision-making, and resource allocation. Proponents of these technologies often tout their potential to increase efficiency, reduce administrative burdens, and improve diagnostic accuracy. However, Dr. Blackstock urges stakeholders to look beyond the technological promise and examine the foundational architecture of these systems.

Throughout the conversation, Dr. Blackstock articulates a deep skepticism toward technology that presents itself as value-neutral. Because algorithms are trained on historical data—data that frequently reflects decades of systemic inequities, unequal access, and documented disparities in medical treatment—they can easily internalize and automate human biases under the guise of mathematical objectivity.

One of the central themes of the episode is how average performance metrics can often conceal unequal harm. When an AI model is evaluated on its aggregate performance across an entire population, it may appear highly successful. Yet, beneath that broad statistical average, the tool may perform significantly worse for specific demographic groups, leading to misdiagnoses, delayed interventions, or denied care for vulnerable populations. Dr. Blackstock warns that relying solely on macro-level performance metrics allows systemic failures to hide in plain sight.

To counteract these risks, Dr. Blackstock argues that AI governance should not be left exclusively to corporate developers, technical review boards, or traditional regulators. Instead, she contends that the communities these tools are ultimately meant to serve must have a direct voice in shaping how algorithms are designed, tested, and deployed. True equity requires a fundamental shift in perspective, moving from retroactive damage control to proactive, inclusive design from the ground up.

Furthermore, Dr. Blackstock makes a compelling business case for equity. Far from being a mere compliance checkbox or an ethical add-on, prioritizing equity is essential for the long-term sustainability, efficacy, and trustworthiness of healthcare institutions. She describes trust not as an intangible feeling, but as a critical piece of infrastructure that can—and must—be deliberately engineered into the healthcare system. Without foundational trust, particularly among historically marginalized patient populations who have experienced institutional mistreatment, new technologies will face widespread resistance and fail to achieve their intended health outcomes.

The conversation ultimately confronts a stark reality: Will the ongoing AI revolution reach the patients that American healthcare has historically failed, or will it simply pass them by? Dr. Blackstock’s insights challenge healthcare leaders, policymakers, and technologists to ensure that the future of medicine is inclusive, accountable, and just.

The Host: Charles N. Kahn III

Guiding this vital conversation is Charles N. Kahn III, a veteran healthcare policy expert and analyst. Kahn serves as a senior visiting fellow at KFF, a leading independent source for health policy research, polling, and journalism.

In addition to his work at KFF, Kahn brings extensive academic and institutional experience to The Business of Health. He is a visiting senior fellow at the American Enterprise Institute and a nonresident senior scholar at the University of Southern California’s Schaeffer Center for Health Policy & Economics. His leadership extends internationally as well, serving as co-chair of the international Future of Health collaborative.

Through The Business of Health, Kahn engages key industry figures in deep-dive discussions designed to demystify the complex economic and structural forces driving modern medicine. The podcast’s ongoing series on artificial intelligence specifically illuminates how emerging technologies are reshaping the healthcare landscape, featuring candid conversations with the individuals deploying these tools, managing their unintended consequences, and drafting the policies meant to govern them.

The Guest: Dr. Uche Blackstock

Dr. Uche Blackstock is a nationally recognized physician, speaker, and author dedicated to dismantling systemic racism in healthcare. As the founder and CEO of Advancing Health Equity, she partners with healthcare organizations, public health departments, and corporate leaders to build accountable systems where all patients and providers can thrive.

Before establishing her consulting firm, Dr. Blackstock spent years on the frontlines of academic medicine and emergency care. Her tenure at NYU Langone Health included serving as an associate professor in the Department of Emergency Medicine and leading diversity, inclusion, and faculty retention efforts within the Office of Diversity Affairs. Her academic background provides her with a unique, insider perspective on how institutional cultures and medical training programs influence patient care and health outcomes.

Dr. Blackstock’s public platform expanded significantly with the publication of her memoir and critique, Legacy: A Black Physician Reckons with Racism in Medicine, which resonated with readers nationwide and secured a spot on the New York Times bestseller list. By bridging clinical practice, public health advocacy, and organizational strategy, she continues to help healthcare organizations move past superficial intentions and achieve measurable, lasting structural change.

As The Business of Health with Chip Kahn continues its exploration of artificial intelligence, episodes like this one underscore the urgency of integrating equity into the core business and operational models of modern healthcare.